Zevacor

Dulles, United States Founded: 2013 • Age: 13 yrs Acquired By Curium
Radiolabeling radiopharmaceutical manufacturing services for nuclear medicine and molecular imaging
Request Access

About Zevacor

Zevacor is a company based in Dulles (United States) founded in 2013 was acquired by Curium in March 2020.. Zevacor operates in a competitive market with competitors including ImaginAb, AC Immune, APRINOIA, BioTelemetry and Innovate Biopharma, among others.

  • Headquarter Dulles, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Healthcare → Healthcare Services & Infrastructure
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    SOFIE

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Curium

    & 1 more

    (Mar 03, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Zevacor
Headcount 200-500
Employee Profiles 3
Employee Profiles
People
Trevor Subero
Senior Director Business Development

Unlock access to complete

Teams

Funding Insights of Zevacor

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Zevacor

Zevacor has secured backing from 2 investors. Prominent investors backing the company include SOFIE and Curium Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Curium Pharma is recognized as a leader in radiopharmaceuticals.
Founded Year Domain Location
Developer of molecular imaging systems and radio-pharmaceuticals
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Zevacor

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Zevacor

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Zevacor Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Zevacor

Zevacor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, APRINOIA, BioTelemetry and Innovate Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
domain founded_year HQ Location
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
domain founded_year HQ Location
Diagnostics and therapeutics for neurodegenerative disorders are developed.
domain founded_year HQ Location
Wireless products for monitoring health parameters are offered.
domain founded_year HQ Location
Small molecule drugs and imaging agent for GI disorders
domain founded_year HQ Location
Imaging compounds & targeted radiotherapies to detect and treat prostate cancer.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Zevacor

Frequently Asked Questions about Zevacor

When was Zevacor founded?

Zevacor was founded in 2013.

Where is Zevacor located?

Zevacor is headquartered in Dulles, United States. It is registered at Dulles, Virginia, United States.

What does Zevacor do?

Zevacor is focussed on developing radiopharmaceutical products and supporting services for use in nuclear medicine and molecular imaging. It provides its services through its subsidiaries Zevacor Pharma and Zevacor Molecular formerly IBA Molecular). Zevacor Molecular manufactures PET and SPECT radiopharmaceuticals and is working on the construction of a new 70 MeV cyclotron and multiple synthesis and processing units for production and distribution of a broad range of clinical and research radioisotopes. Zevacor Pharma provides investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions nationwide for the development of the next generation of molecular imaging and therapeutic products.

Who are the top competitors of Zevacor?

Zevacor's top competitors include ImaginAb, AC Immune and APRINOIA.

Who are Zevacor's investors?

Zevacor has 2 investors. Key investors include SOFIE, and Curium Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available